Cargando…
Protecting the heart
Blocking a protein known as EPAC1 may prevent the development of heart-related side effects caused by a chemotherapy drug.
Autores principales: | Inglis, Joshua M, Mangoni, Arduino A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482425/ https://www.ncbi.nlm.nih.gov/pubmed/37672034 http://dx.doi.org/10.7554/eLife.91831 |
Ejemplares similares
-
EPAC1 inhibition protects the heart from doxorubicin-induced toxicity
por: Mazevet, Marianne, et al.
Publicado: (2023) -
Targeting LMW‐PTP to sensitize melanoma cancer cells toward chemo‐ and radiotherapy
por: Lori, Giulia, et al.
Publicado: (2018) -
Fishing for protective compounds
por: Ciarimboli, Giuliano
Publicado: (2020) -
Inactivation of the ATMIN/ATM pathway protects against glioblastoma formation
por: Blake, Sophia M, et al.
Publicado: (2016) -
Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy
por: LoCoco, Peter M, et al.
Publicado: (2017)